Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 70875601000001113 | Salicylic acid + Starch + Zinc oxide (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 70875701000001115 | Salicylic acid + Starch + Zinc oxide | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Salicylic acid + Starch + Zinc oxide | Is a | Product containing salicylic acid | false | Inferred relationship | Existential restriction modifier | ||
| Salicylic acid + Starch + Zinc oxide | Is a | Product containing starch and zinc oxide | true | Inferred relationship | Existential restriction modifier | ||
| Salicylic acid + Starch + Zinc oxide | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Salicylic acid + Starch + Zinc oxide | Has active ingredient | Starch | true | Inferred relationship | Existential restriction modifier | ||
| Salicylic acid + Starch + Zinc oxide | Has active ingredient | Zinc oxide | true | Inferred relationship | Existential restriction modifier | ||
| Salicylic acid + Starch + Zinc oxide | Has active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Salicylic acid 1% / Starch 12% / Zinc oxide 12% in White soft paraffin | Is a | True | Salicylic acid + Starch + Zinc oxide | Inferred relationship | Existential restriction modifier | |
| Zinc and Salicylic acid paste | Is a | True | Salicylic acid + Starch + Zinc oxide | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR